MedPath

E-COMPARED - internet-supported CBT for depressio

Not Applicable
Completed
Conditions
Major depressive disorder
Mental and Behavioural Disorders
Registration Number
ISRCTN12388725
Lead Sponsor
ondon School of Hygiene and Tropical Medicine
Brief Summary

2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/27488181 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32967872/ Qualitative working alliance results (added 25/09/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35876079/ Practitioners' experience of the working alliance (added 26/07/2022) 2024 Results article in https://doi.org/10.2196/47515 Secondary Data Analysis (added 03/06/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

1. 18 years of age or older
2. Scoring more than 5 points on PHQ-9
3. Meet DSM-IV diagnostic criteria for Major Depression Disorder as confirmed by the telephone administered MINI International Neuropsychiatric Interview version 5.0

Exclusion Criteria

1. Current high risk for suicide according to the MINI Interview section C
2. Serious psychiatric co-morbidity that requires alternative treatment including substance dependence, bipolar affective disorder, psychotic illness or obsessive compulsive disorder as established at the MINI interview
3. Currently receiving psychological treatment for depression in primary or specialised mental health care
4. Being unable to comprehend, speak, read or write English
5. Not having access to a fast internet connection (i.e., broadband or comparable)
6. Not having or being unable to set up an email address that can be used to communicate with the therapist and research team

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure will be Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a nine-item mood module that can be used to screen and to diagnose patients with depressive disorders. Outcomes will be measured on both arms at baseline, end of treatment (12 weeks), 6 months and 12 months.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath